Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
Authors:
- Marie-Lise Jaffrain-ReaMJMarie-Lise Jaffrain-Rea
- Sandra RotondiSRSandra Rotondi
- Annarita TurchiATAnnarita Turchi
- Gianluca OcchiGOGianluca Occhi
- Anne BarlierABAnne Barlier
- Erika PeverelliEPErika Peverelli
- Lilya RostomyanLRLilya Rostomyan
- Céline DefillesCDCéline Defilles
- Mariolina AngeliniMAMariolina Angelini
- Maria-Antonietta OlivaMOMaria-Antonietta Oliva
- Filippo CeccatoFCFilippo Ceccato
- Orlando MaioraniOMOrlando Maiorani
- 12 August 2013
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 20 (5) , 753-766
Abstract
Germline aryl hydrocarbon receptor interacting protein (AIP) gene mutations confer a predisposition to pituitary adenoma (PA), predominantly GH-secreting (GH-PA). As recent data suggest a role for AIP in the pathogenesis of sporadic GH-PA and their response to somatostatin analogues (SSA), the expression of AIP and its partner, aryl hydrocarbon receptor (AHR), was determined by semiquantitative immunohistochemistry scoring in 62 sporadic GH-PA (37 treated with SSA preoperatively). The influence ofGspstatus was studied in a subset of tumours (n=39, 14Gsp+) and six GH-PA were available for primary cultures. AIP and AHR were detected in most cases, with a positive correlation between AIP and cytoplasmic AHR (P=0.012). Low AIP expression was significantly more frequent in untreated vs SSA-treated tumours (44.0 vs 20.5%,P=0.016). AHR expression or localisation did not differ between the two groups. Similarly,in vitrooctreotide induced a median twofold increase in AIP expression (range 1.2–13.9,P=0.027) in GH-PA. In SSA-treated tumours, the AIP score was significantly higher in the presence of preoperative IGF1 decrease or tumour shrinkage (P=0.008 andP=0.014 respectively). In untreated tumours, low AIP expression was significantly associated with invasiveness (P=0.028) and suprasellar extension (P=0.019). The only effect ofGspstatus was a significantly lower nuclear AHR score inGsp+vsGsp−tumours (P=0.025), irrespective of SSA. In conclusion, AIP is involved in the aggressiveness of sporadic GH-PA, regardless ofGspstatus, and AIP up-regulation in SSA-treated tumours is associated with a better preoperative response, with no clear role for AHR.Keywords
This publication has 42 references indexed in Scilit:
- Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) GeneEndocrine Reviews, 2013
- Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 PathwayThe Journal of Clinical Endocrinology & Metabolism, 2012
- The Immunophilin-Like Protein XAP2 Is a Negative Regulator of Estrogen Signaling through Interaction with Estrogen Receptor αPLOS ONE, 2011
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative StudyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Pituitary somatostatin receptor signalingTrends in Endocrinology & Metabolism, 2010
- The Aryl Hydrocarbon Receptor Complex and the Control of Gene ExpressionCritical Reviews™ in Eukaryotic Gene Expression, 2008
- Mutations in theAryl Hydrocarbon Receptor Interacting ProteinGene Are Not Highly Prevalent among Subjects with Sporadic Pituitary AdenomasThe Journal of Clinical Endocrinology & Metabolism, 2007
- Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 FamiliesThe Journal of Clinical Endocrinology & Metabolism, 2007
- Attenuation of the Activity of the cAMP-specific Phosphodiesterase PDE4A5 by Interaction with the Immunophilin XAP2Journal of Biological Chemistry, 2003
- Pronostic and Therapeutic Consequences of Gs Mutations in Somatotroph AdenomasThe Journal of Clinical Endocrinology & Metabolism, 1998